Navigation Links
Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
Date:9/10/2007

BARCELONA, Spain, Sept. 10 /PRNewswire/ -- Elekta today unveiled a new member of the Elekta family of linear accelerators at the European Society of Therapeutic Radiation Oncologists (ESTRO) 2007 meeting. At an 11 a.m. unveiling ceremony in the Elekta booth, Elekta President and CEO Tomas Puusepp announced the launch of Elekta Compact(TM), a new addition to Elekta's product line of linear accelerators that offers an easy to implement, more affordable solution for radiation therapy.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

Elekta Compact purposefully was designed with a single low-energy photon beam and a small footprint specifically, so it is ideally positioned for use in a small treatment room and in specialized markets. Its efficient design makes it more accessible to a wider range of health care providers who want to give their patients the optimal care in radiation therapy. "Elekta is committed to fighting cancer and enhancing patients' quality of life," says Puusepp. "With the addition of Elekta Compact to our product portfolio, Elekta is now a provider of linear accelerators across the full spectrum of price and performance specifications."

Smaller footprint targets untapped markets

In rooms that previously contained a Cobalt unit, or a treatment room with limited space, Elekta Compact may be an appropriate first step. "For former Cobalt users who want a simple linear accelerator that is a 'workhorse' in providing cancer treatment with fewer complications, Elekta Compact can fill a treatment room that might otherwise lay empty," says Olof Sanden, Executive Vice President, Elekta, Europe.

Elekta Compact was designed and positioned to give all customers access to this exceptional product. "We haven't forgotten that there's a need for appropriate products to meet all customers' needs," says Russ Cox, Manager of Oncology Product Management and Senior Product Manager of Precision Radiation Therapy Systems at Elekta. "For countries needing to rapidly increase treatment capacity and those countries where Cobalt replacements are becoming more common, this is an ideal machine."

Elekta Compact users will have access to electronic treatment records and sophisticated information management systems to help streamline workflow. "Elekta Compact begins as a simple point-and-shoot precision radiation treatment system," says Cox, "and we make available an interface to allow the output of treatment parameters to external record-and-verify systems such as the MOSAIQ(TM) system provided by Elekta."

Elekta Compact upgradeable to higher-end product

Elekta Compact has various upgrade paths to a higher-value product. "A mini multi-leaf collimator from Elekta can be mounted along with associated small field cones for stereotactic radiotherapy and radiosurgery," explains Cox. In addition, the user can start with an Elekta Precise standard tabletop and upgrade to all forms of carbon fiber tabletops based on the customer's individual clinical needs.

In keeping with Elekta's ESTRO theme, "Moving forward together," Elekta is showcasing the entire Elekta family of products, services and companies, including Elekta's flagship products together with integrated product innovations from all Elekta companies.

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include, among others, Leksell Gamma Knife(R) product line for non-invasive treatment of brain disorders, Elekta Axesse(TM) for Image guided Stereotactic treatments, and Elekta Synergy(R) for intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world's largest supplier of oncology software.

Elekta's systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approximately 2,000 employees, Elekta's corporate headquarters is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit http://www.elekta.com.


'/>"/>
SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
(Date:2/16/2017)... (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the power of ... negative breast cancer (TNBC), announced today their completion of the ... The YEi Start in France ... business in France and Europe.  ImMAGE ... an intensive one week immersion in France ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
Breaking Biology News(10 mins):